Cargando…
Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients
OBJECTIVES: Oocyte and/or embryo vitrification after controlled ovarian stimulation (COS) represents the most established method of fertility preservation (FP) before cancer treatment. However, traditional COS regimens are associated with supraphysiologic serum estradiol and are therefore not recomm...
Autores principales: | Sonigo, Charlotte, Sermondade, Nathalie, Calvo, Jéremy, Benard, Julie, Sifer, Christophe, Grynberg, Michaël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817658/ https://www.ncbi.nlm.nih.gov/pubmed/31673686 http://dx.doi.org/10.1016/j.eurox.2019.100049 |
Ejemplares similares
-
Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible
por: Sermondade, Nathalie, et al.
Publicado: (2020) -
Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation
por: El Hachem, Hady, et al.
Publicado: (2018) -
OR20-01 AMH Preserves Fertility in Chemotherapy-Treated Mice Through a Mechanism Involving Autophagy
por: Beau, Isabelle, et al.
Publicado: (2020) -
Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial
por: Benoit, Alexandra, et al.
Publicado: (2020) -
Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
por: Lalami, Imane, et al.
Publicado: (2022)